Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma
(2019)
Journal Article
BACKGROUND In double-blind, placebo-controlled trials, budesonide–formoterol used on an as-needed basis resulted in a lower risk of severe exacerbation of asthma than as-needed use of a short-acting β2-agonist (SABA); the risk was similar to that of... Read More about Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma.